Rheumatoid arthritis is also a chronic autoimmune ... One is fairly obvious: the presence of psoriasis lesions. That’s a cue ...

This study seeks to show that it’s possible to reverse both Rheumatoid Arthritis (RA) and Psoriasis by integrating conventional treatments with personalized interventions that target underlying ...

Sotyktu is approved to treat plaque psoriasis by the US Food and Drug Administration (FDA ... took a hit after the company ...

MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I drugs for Multiple Sclerosis have a 72% phase transition success ...

Psoriasis is a sign that your immune system is not working properly. Proactively managing and making lifestyle changes to maintain a strong immune system may help reduce psoriasis flare-ups. While ...

juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical trials, the most common adverse effect of this ...

Sunshine Lake Pharma Co Ltd. has divulged non-receptor tyrosine-protein kinase TYK2 inhibitors reported to be useful for the treatment of multiple sclerosis, psoriasis, rheumatoid arthritis, atopic ...